Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Chlor Alkali Products & Vinyls | 5,085.0 | 4,140.8 | 2,959.9 | 3,420.1 | 3,986.7 | 3,500.8 | 2,999.3 | 1,713.4 |
Epoxy | 2,690.5 | 3,186.0 | 1,870.5 | 2,024.4 | 2,303.1 | 2,086.4 | 1,822.0 | 429.6 |
Other foreign | 2,106.3 | 1,961.8 | 1,420.6 | 1,520.1 | 1,817.8 | 1,629.8 | 1,271.5 | |
Winchester | 1,600.7 | 1,583.8 | 927.6 | 665.5 | 656.3 | 681.2 | 729.3 | 711.4 |
Total revenues | 9,376.2 | 8,910.6 | 5,758.0 | 6,110.0 | 6,946.1 | 6,268.4 | 5,550.6 | 2,854.4 |
Revenue growth [+] | 5.2% | 54.8% | -5.8% | -12.0% | 10.8% | 12.9% | 94.5% | 27.4% |
Chlor Alkali Products & Vinyls | 22.8% | 39.9% | -13.5% | -14.2% | 13.9% | 16.7% | 75.0% | 14.0% |
Epoxy | -15.6% | 70.3% | -7.6% | -12.1% | 10.4% | 14.5% | 324.1% | |
Other foreign | 7.4% | 38.1% | -6.5% | -16.4% | 11.5% | 28.2% | | |
Winchester | 1.1% | 70.7% | 39.4% | 1.4% | -3.7% | -6.6% | 2.5% | -3.7% |
Cost of goods sold | 7,194.3 | 6,616.4 | 5,374.6 | 5,439.2 | 5,822.1 | 5,554.9 | 4,944.5 | 2,486.8 |
Gross profit | 2,181.9 | 2,294.2 | 383.4 | 670.8 | 1,124.0 | 713.5 | 606.1 | 367.6 |
Gross margin | 23.3% | 25.7% | 6.7% | 11.0% | 16.2% | 11.4% | 10.9% | 12.9% |
Selling, general and administrative | 393.9 | 416.9 | 422.0 | 416.9 | 430.6 | 369.8 | 347.2 | 186.3 |
Research and development | | | | | | | | |
Equity in earnings | | | | | -19.7 | 1.8 | 1.7 | 1.7 |
Other operating expenses | -40.3 | -20.5 | -9.3 | -82.0 | -25.2 | -48.5 | -10.6 | -45.7 |
EBITDA [+] | 2,427.1 | 2,480.3 | 539.1 | 933.3 | 1,300.3 | 952.9 | 804.7 | 457.6 |
EBITDA growth | -2.1% | 360.1% | -42.2% | -28.2% | 36.5% | 18.4% | 75.9% | 25.6% |
EBITDA margin | 25.9% | 27.8% | 9.4% | 15.3% | 18.7% | 15.2% | 14.5% | 16.0% |
Depreciation and amortization | 598.8 | 582.5 | 568.4 | 597.4 | 601.4 | 558.9 | 533.5 | 228.9 |
EBIT [+] | 1,828.3 | 1,897.8 | -29.3 | 335.9 | 698.9 | 394.0 | 271.2 | 228.7 |
EBIT growth | -3.7% | -6577.1% | -108.7% | -51.9% | 77.4% | 45.3% | 18.6% | 1.6% |
EBIT margin | 19.5% | 21.3% | -0.5% | 5.5% | 10.1% | 6.3% | 4.9% | 8.0% |
Non-recurring items [+] | 49.3 | 47.0 | 717.4 | 158.1 | 41.7 | 95.6 | 161.7 | 126.1 |
Asset impairment | | | 699.8 | | | | | |
Interest expense, net [+] | 141.7 | 347.8 | 292.2 | 242.2 | 241.6 | 215.6 | 188.5 | 95.9 |
Interest expense | 143.9 | 348.0 | 292.7 | 243.2 | 243.2 | 217.4 | 191.9 | 97.0 |
Interest income | 2.2 | 0.2 | 0.5 | 1.0 | 1.6 | 1.8 | 3.4 | 1.1 |
Other income (expense), net [+] | 38.7 | 35.7 | 18.9 | 27.5 | 21.7 | 34.4 | 44.8 | |
Other non-operating income | | | | 11.2 | | | | |
Other | -24.2 | -16.2 | -20.9 | 47.7 | 7.3 | | | |
Pre-tax income | 1,676.0 | 1,538.7 | -1,020.0 | -36.9 | 437.3 | 117.2 | -34.2 | 6.7 |
Income taxes | 349.1 | 242.0 | -50.1 | -25.6 | 109.4 | -432.3 | -30.3 | 8.1 |
Tax rate | 20.8% | 15.7% | 4.9% | 69.4% | 25.0% | | 88.6% | 120.9% |
Net income | 1,326.9 | 1,296.7 | -969.9 | -11.3 | 327.9 | 549.5 | -3.9 | -1.4 |
Net margin | 14.2% | 14.6% | -16.8% | -0.2% | 4.7% | 8.8% | -0.1% | 0.0% |
|
Basic EPS [+] | $9.16 | $8.15 | ($6.14) | ($0.07) | $1.97 | $3.31 | ($0.02) | ($0.01) |
Growth | 12.4% | -232.7% | 8722.4% | -103.5% | -40.5% | -14105.0% | 74.4% | -101.0% |
Diluted EPS [+] | $8.94 | $7.96 | ($6.14) | ($0.07) | $1.95 | $3.26 | ($0.02) | ($0.01) |
Growth | 12.3% | -229.5% | 8722.4% | -103.6% | -40.3% | -13913.8% | 74.4% | -101.0% |
|
Dividends per share [+] | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 |
Growth | -0.2% | 0.4% | 0.4% | -0.4% | 0.0% | 0.0% | 0.0% | 0.0% |
|
Shares outstanding (basic) [+] | 144.9 | 159.1 | 157.9 | 162.3 | 166.8 | 166.2 | 165.2 | 103.4 |
Growth | -8.9% | 0.8% | -2.7% | -2.7% | 0.4% | 0.6% | 59.8% | 31.6% |
Shares outstanding (diluted) [+] | 148.5 | 163.0 | 157.9 | 162.3 | 168.4 | 168.5 | 165.2 | 103.4 |
Growth | -8.9% | 3.2% | -2.7% | -3.6% | -0.1% | 2.0% | 59.8% | 29.7% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|